How to find an FDA product code for a medical device
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Medical-device intelligence
FDA product code SBY: High Throughput Sequencing Based Tumor Profiling Test Of Circulating Cell-Free Nucleic Acids. View classification details, related manufacturers, 510(k) clearances, and recall records.
A high throughput sequencing based tumor profiling test of circulating cell-free nucleic acids is a qualitative in vitro diagnostic test intended for next generation sequencing analysis of circulating cell-free nucleic acids from plasma samples collected from peripheral whole blood to detect mutations in a panel of targeted genes to aid in the management of previously diagnosed cancer patients by qualified health care professionals. The results of the test are not prescriptive or conclusive for use of any specific therapeutic product.Explore pathology records →
1 clearance records and 0 recall records in the covered releases, across 1 source company names and 1 product codes. Dated history runs from Oct 15, 2026 to Oct 15, 2026.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 1 | 0 |
| Code and FDA device name | Clearances | Recalls |
|---|---|---|
| SBY · High Throughput Sequencing Based Tumor Profiling Test Of Circulating Cell-Free Nucleic Acids | 1 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| Oncomine Dx Express TestK260827 · SBY | Life Technologies Corporation | 510(k) | Oct 15, 2026FDA decision date |
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Understand the K number, applicant, decision date, product code, and limits of the public clearance record.
Read the guide →FDA dataset:
Last successful check: Nov 21, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 21, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 21, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.